BIOCUBAFARMA

The Biotechnological and Pharmaceutical Industries Group (BioCubaFarma) signed a new cooperation agreement with Chinese joint venture Changheber for the introduction of innovative immunotherapy for the treatment of cancer in the Asian country, it announced via Twitter»

Next Wednesday, April 14th, Cuba and Germany will discuss new areas for cooperation»

Interferon alpha 2B, a Cuban drug used in China for coronavirus treatment, will be among the products to be exhibited in Mexico»

The biopharmaceutical industry is one of the country's strategic economic sectors»